Simtuzumab
Simtuzumab is a monoclonal antibody against lysyl oxidase-like protein 2 (LOXL2) . Simtuzumab can be used to treat primary sclerosing cholangitis (PSC) and is not effective in patients with bridging fibrosis or compensatory cirrhosis caused by non-alcoholic steatohepatitis.
Product Specifications
Stability
≥ 2 years
Purity
>98% (HPLC)
Molecular Formula
——
Notes
Research use only, not for human use.
Receptor
Monoamine Oxidase
CAS Number
1318075-13-6
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS6250702-01 0.1 mL
CD8 alpha, beta (CD8 alpha, CD8a, CD8 alpha Chain, CD8 Antigen alpha Chain, CD8 Antigen alpha Polypeptide (p32), CD8 beta, CD8b, CD8 Antigen beta Polypeptide 1, CD8B1, Leu2 T Lymphocyte Antigen, Leu-2, Leu2, Ly3, LYT3, MAL, MGC119115, OKT8 T cell Antigen,
Ask
View Details 
MBS6250702-02 5x 0.1 mL
CD8 alpha, beta (CD8 alpha, CD8a, CD8 alpha Chain, CD8 Antigen alpha Chain, CD8 Antigen alpha Polypeptide (p32), CD8 beta, CD8b, CD8 Antigen beta Polypeptide 1, CD8B1, Leu2 T Lymphocyte Antigen, Leu-2, Leu2, Ly3, LYT3, MAL, MGC119115, OKT8 T cell Antigen,
Ask
View Details 